- How the Conference Started
- Increased Need for Knowledge
- Past Conferences
- Future Conferences
How the Conference Started
In 1957, Theodore Gleichman, in private practice in Denver, approached Roger S. Mitchell, Chief of the Pulmonary Disease Division and Director of the Webb-Waring Lung Institute with a proposal. His idea was to establish a conference for the exchange of new ideas and presentation of new research on emphysema and related topics. At that time, emphysema was a poorly understood disease.
Together with Giles F. Filley and John R.(Jack) Durrance the Aspen Emphysema Conference was planned. Funds for the first conference in 1958, as well as the next ten, were readily obtainable from grants from the National Institutes of Health. The proceedings of the 1958 Conference were published as a special supplement to the American Review of Respiratory Diseases. The conference was off to a good start.
In 1965, Tom Petty organized the Conference on therapy for chronic obstructive pulmonary disease (COPD). This became a landmark conference because it dealt, for the first time, with systematic care for "respiratory cripples".
In 1980, Dr. Petty established the Aspen Lung Conference Endowment Fund with contributions from former fellows, attendees, and some major contributions from the pharmaceutical industry to help insure partial funding for future conferences. In 1989, the conference was renamed in honor of Tom Petty who has worked tirelessly over the years, organizing and chairing at least eight of the conferences. Beginning with the 33rd Conference conducted in 1990, the conference became known as the "Thomas L. Petty Aspen Lung Conference".
The Aspen Conference is made unique by its multidisciplinary format and international scope. It is an idea forum for both the established scientists and in particular the young investigator, allowing them to present their work in the atmosphere of a symposium in front of experts in the field.
Increased Need for Knowledge
The importance of gathering and disseminating knowledge dealing with lung disease is accentuated when we realize that the awareness of lung problems today is at the same stage hypertension was 20 years ago. The need for rapid growth is further evident in the fact that at least 30 million people suffer from emphysema, asthma, and chronic bronchitis in the United States alone. As many as 10 million are undiagnosed. Furthermore, "respiratory cripples" - those people restricted in their ability to earn a living - are growing in number. Knowledge is the key in the battle to prevent and manage lung disease.
As many as 100,000 copies of the proceedings are distributed annually throughout the world. The Conference continues to be a tremendous source of knowledge, providing increasing insight into basic mechanisms, diagnosis and management of pulmonary disease.
In the past, Dr. Petty raised the funds to support the conferences from many different sources including industry, foundations, lung associations, personal friends, and patients. Beginning in 1985, Dr. Marvin Schwarz, Head of the Division of Pulmonary Sciences and Critical Care Medicine took over the administrative management of the conference. In February 2002, the Thomas L. Petty Aspen Lung Conference became a not-for-profit corporation. They continue each year to seek the support of industry to further the traditions and scientific excellence of the Thomas L. Petty Aspen Lung Conference.
Your tax deductible contribution will advance knowledge and help lung care patients to receive the type of diagnosis and management now available to patients suffering from hypertension, diabetes, heart trouble and other diseases.
Please send your contribution made payable to:
Aspen Lung Conference
PO Box 1622
Parker, Colorado 80134
Tax ID#: 84-1606032
Emphysema and Chronic Bronchitis (1958)
Pulmonary Mechanics (1959)
Air Pollution (1960)
Pulmonary Circulation (1962)
Adaptation to Atmosphere (1963)
Management of Emphysema & Chronic Bronchitis (1965)
Current Research (1966-70)
Acid-Base & Blood Gas Transport (1971)
Adult Respiratory Disease Syndrome (1973)
Basic Science & the Lung (1974)
Interstitial Lung Disease (1975)
The Pulmonary Circulation (1976)
Neuromuscular & Chemical Control of Breathing (1977)
Immunology of the Lung (1978)
Chronic Obstructive Pulmonary Disease (Epidemiology, Course & Prognosis, Intervention) (1979)
The Environment & the Lung (1980)
Bronchopulmonary Secretions & Fluids (1981)
Lung Defense, Injury & Repair (1982)
Interstitial Lung Diseases (1985)
Molecular & Cellular Biology of Lung Cancer (1986)
Pulmonary Circulation and Pulmonary Hypertension (1987)
Infections and the Lung (1988)
Chronic Respiratory Failure (1989)
Mechanisms of Lung Repair (1990)
Epithelial Cell Biology and Airway Disease (1991)
Immunology of the Lung (1992)
Acute Lung Injury (1993)
Asthma: Structure & Function (1994)
Environmental Lung Disease:
Exposures & Mechanisms (1995)
Genes and Gene Therapy (1996)
Biology & Pathobiology of the Lung Circulation (1997)
Acute Lung Injury (1998)
Mechanisms of COPD (1999)
Mechanisms of Pulmonary Fibrosis (2000)
Pulmonary Genetics, Genomics and Gene Therapy (2001)
Asthma in the New Millennium (2002)
Lung Cancer (2003)
Cellular and Molecular Pathobiology of Pulmonary Hypertension (2004)
Pathobiology of COPD (2005)
Immunologic Diseases of the Lung (2006)
Lung Injury and Repair (2007)
Asthma: Insights and Expections (2008)
The Environment and the Lung: Detection, Prevention and Mechanisms of Disease (2009)
Systems Biology of Lung Diseases-Progress in the 'Omics' Era (2010)
COPD and Lung Cancer: Common Pathogenesis, Shared Clinical Challenges (2011)
Mechanics and Mechanisms of Pulmonary Hypertension (2012)
The Lung Microbiome: A New Frontier In Pulmonary Medicine (2013)
Rebuilding the Injured Lung (2014)
Asthma 2015: Mechanisms to Personalized Medicine (2015)
Lung Transplant (2016)
Environment and Lung Health: Exposure, Susceptibility and Intervention (2017)
Translating Resilience and Pathogenesis to Personalized Therapy for COPD (2018)